Health news
Ischemic events among individuals with suspected acute coronary syndrome (ACS) were not reduced over a 12-month follow-up when using unmasked 0/1-hour high-sensitivity cardiac troponin T (hs-cTnT) protocol, according to a multicenter prospective randomized study published…
Among patients with cardiovascular diseases who have received an implantable cardiac assistive device, women, individuals with lower income, and those who are divorced are at increased risk for having a more difficult time adjusting to…
Cardiovascular disease (CVD) complications affect up to 4% of all pregnancies, with approximately one-quarter of cases attributable to valvular heart disease.1,2 Overall, risk management guidelines emphasize the potential complications associated with stenotic valvular lesions. Regurgitant…
A uniform unguided de-escalation strategy significantly reduced bleeding events after index percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI), according to findings from an open-label, assessor-masked randomized trial published in The Lancet. In the…
Cardiovascular disease (CVD) event risk in adults with hypertension and left ventricular hypertrophy (LVH) is the lowest at systolic and diastolic blood pressure (BP) less than 130 mm Hg and less than 80 mm Hg,…
A 4-month structured diet and exercise program significantly lowered blood pressure (BP) and body weight among patients with resistant hypertension (RH), according to study findings published in Circulation. In the current study, researchers enrolled patients…
In patients with acute pulmonary embolism (PE) who are nonhypotensive, researchers found a positive association between an elevated heart rate (HR) and increased risk for all-cause mortality, as well as PE-related mortality. Results of the…
When lifestyle-based interventions fall short, physicians may consider pharmacotherapy and surgical interventions for the management of obesity hypertension, according to a scientific statement published in Hypertension. The statement endorsed by the American Heart Association (AHA)—led…
Women with heart failure (HF) are significantly more likely to be physically frail compared with men with HF, according to research results published in Circulation: Heart Failure. Because 1 of every 2 patients with HF…
The widespread use of dapagliflozin for treating heart failure (HF) with reduced ejection fraction (HFrEF) has the potential to improve long-term clinical outcomes and may be a cost-effective treatment, according the a recent study published…
© 2005-2021 Top-Meds - All rights reserved. Our website services, content, and products are for informational purposes only. Top-Meds does not provide medical advice, diagnosis, or treatment. | Medical News 2021